We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Digital Holographic Microscopy Reveals How Cancer Cells Gain Extra Chromosomes

By LabMedica International staff writers
Posted on 22 Nov 2010
Print article
Image: Computer artwork of a chromosomal aberration, with the chromosome at left showing an extra portion of chromatid attached to it - shown at lower center (photo courtesy of Hybrid Medical Animation).
Image: Computer artwork of a chromosomal aberration, with the chromosome at left showing an extra portion of chromatid attached to it - shown at lower center (photo courtesy of Hybrid Medical Animation).
Cell biologists have used digital holographic microscopy to show how abnormal distribution of chromosomes takes place in some types of cancer cells.

Investigators at Lund University (Sweden) used Wilms' tumor as a model for cancers with trisomies. They made movies of the tumor cells growing in culture. To prevent damage to the cells during photography, they employed digital holographic microscopy, a novel technique by which the cells were exposed only to weak laser light for very limited time periods.

Results published in the November 8, 2010, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS) contrasted with the popular theory that dysfunction of the spindle assembly checkpoint (SAC) leads to an accumulation of trisomies through failure to correctly segregate sister chromatids in successive cell divisions. Instead, results of the current study showed that trisomic cells could form even in the presence of a functional SAC through tripolar cell divisions in which sister chromatid separation proceeded in a regular fashion, but cytokinesis failure nevertheless led to an asymmetrical segregation of chromosomes into two daughter cells.

"We were even more surprised to see that two of the three poles often fused together to form one daughter cell. This daughter cell thus got extra copies of one or more chromosomes. When we continued to film the cells it emerged that they could continue to divide, and they thus gave rise to new cancer cells with a chromosome set that was different from the original cell,” said first author Dr. David Gisselsson Nord, associate professor of pathology at the Lund University.

"We have long known that changes in the genetic make-up of body cells play a part in the development of tumors. However, we do not know a lot about how the genetic changes in the tumor cells actually come about. Above all, it has been difficult to understand why many tumor cells contain extra copies of one or more chromosomes, despite the fact that this is the most common type of chromosome abnormality in cancer cells,” said Dr. Nord.

Related Links:
Lund University


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
Flow Cytometer
BF – 710
New
Human Immunodeficiency Virus Assay
RealLine HIV Quantitative Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.